益盛药业
(002566)
| 流通市值：14.34亿 | | | 总市值：20.45亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 85,136,621.92 | 86,160,766.19 | 234,366,000.78 | 63,554,309.91 |
| 交易性金融资产 | 513,264,961.22 | 538,395,743.57 | 400,571,059.79 | 507,572,971.73 |
| 应收票据及应收账款 | 199,797,385.25 | 184,518,721.75 | 174,628,251.08 | 158,945,799.69 |
| 其中：应收票据 | 626,181.48 | 884,435.38 | 1,405,570.2 | 619,612.8 |
| 应收账款 | 199,171,203.77 | 183,634,286.37 | 173,222,680.88 | 158,326,186.89 |
| 应收款项融资 | 38,795,593.21 | 29,221,633.77 | 32,620,147.29 | 55,947,268.14 |
| 预付款项 | 10,252,916.78 | 18,267,462.79 | 10,248,683.65 | 8,350,250.88 |
| 其他应收款合计 | 23,302,770.48 | 19,115,194.46 | 24,695,767.87 | 20,895,916.56 |
| 存货 | 1,559,004,653.41 | 1,571,750,615.01 | 1,575,238,923.19 | 1,581,017,839.16 |
| 其他流动资产 | 2,014,870.3 | 1,223,041.68 | 1,693,941.7 | 1,519,026.79 |
| 流动资产合计 | 2,431,569,772.57 | 2,448,653,179.22 | 2,454,062,775.35 | 2,397,803,382.86 |
| 非流动资产: | | | | |
| 固定资产 | 380,639,199.59 | 388,859,040.69 | 397,115,072.2 | 405,862,497.42 |
| 使用权资产 | 11,889,838.81 | 12,695,284.02 | 10,585,028.57 | 11,266,419.75 |
| 无形资产 | 106,653,373.88 | 107,323,039.15 | 108,127,322.49 | 108,664,697.58 |
| 商誉 | 1,905,827.33 | 1,905,827.33 | 1,905,827.33 | 1,905,827.33 |
| 长期待摊费用 | 1,104,656.07 | 1,215,853.96 | 1,333,213.83 | 1,542,556.65 |
| 递延所得税资产 | 20,412,094.37 | 16,980,176.66 | 16,388,121.85 | 15,847,461.1 |
| 其他非流动资产 | 16,482,463.35 | 16,553,352.52 | 16,703,984.19 | 16,728,775.87 |
| 非流动资产合计 | 539,087,453.4 | 545,532,574.33 | 552,158,570.46 | 561,818,235.7 |
| 资产总计 | 2,970,657,225.97 | 2,994,185,753.55 | 3,006,221,345.81 | 2,959,621,618.56 |
| 流动负债: | | | | |
| 短期借款 | 328,218,830.58 | 328,216,608.35 | 333,221,858.34 | 288,228,800 |
| 应付票据及应付账款 | 8,238,074.2 | 13,557,169.52 | 13,166,642.33 | 11,691,311.81 |
| 应付账款 | 8,238,074.2 | 13,557,169.52 | 13,166,642.33 | 11,691,311.81 |
| 合同负债 | 11,798,627.01 | 9,819,025.41 | 10,590,160.89 | 14,769,280.64 |
| 应付职工薪酬 | 6,223,288.99 | 9,774,106.5 | 8,674,306.7 | 7,674,323.46 |
| 应交税费 | 4,976,542.55 | 10,285,337.31 | 11,901,868.89 | 9,183,064.94 |
| 其他应付款合计 | 24,569,404.11 | 28,399,485.87 | 24,896,514.58 | 27,959,861.59 |
| 一年内到期的非流动负债 | 3,092,329.39 | 3,455,197.37 | 2,677,740.11 | 2,697,933.42 |
| 其他流动负债 | 18,908,812.12 | 18,658,508.1 | 13,382,232.32 | 21,899,083.1 |
| 流动负债合计 | 406,025,908.95 | 422,165,438.43 | 418,511,324.16 | 384,103,658.96 |
| 非流动负债: | | | | |
| 长期借款 | 129,600,000 | 129,600,000 | 129,700,000 | 129,700,000 |
| 租赁负债 | 4,154,734.72 | 4,252,836.69 | 3,436,086.34 | 5,341,226.63 |
| 递延收益 | 106,445,789.5 | 105,189,915.83 | 106,407,886.79 | 108,867,495.85 |
| 递延所得税负债 | 1,054,100.83 | 2,355,686.17 | 2,673,479.08 | 2,339,823.36 |
| 非流动负债合计 | 241,254,625.05 | 241,398,438.69 | 242,217,452.21 | 246,248,545.84 |
| 负债合计 | 647,280,534 | 663,563,877.12 | 660,728,776.37 | 630,352,204.8 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 330,951,600 | 330,951,600 | 330,951,600 | 330,951,600 |
| 资本公积 | 834,689,338.39 | 834,689,338.39 | 834,689,338.39 | 834,689,338.39 |
| 盈余公积 | 147,619,593.3 | 147,619,593.3 | 147,619,593.3 | 147,619,593.3 |
| 未分配利润 | 913,014,119.21 | 918,605,229.58 | 934,394,536.31 | 918,250,249.1 |
| 归属于母公司股东权益合计 | 2,226,274,650.9 | 2,231,865,761.27 | 2,247,655,068 | 2,231,510,780.79 |
| 少数股东权益 | 97,102,041.07 | 98,756,115.16 | 97,837,501.44 | 97,758,632.97 |
| 股东权益合计 | 2,323,376,691.97 | 2,330,621,876.43 | 2,345,492,569.44 | 2,329,269,413.76 |
| 负债和股东权益合计 | 2,970,657,225.97 | 2,994,185,753.55 | 3,006,221,345.81 | 2,959,621,618.56 |
| 公告日期 | 2026-10-27 | 2026-08-25 | 2026-04-25 | 2026-04-17 |
| 审计意见(境内) | | | | 标准无保留意见 |